These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1820705)

  • 1. Don't kill the parasite: control the disease.
    Playfair JH; Taverne J; Bate CA
    Acta Leiden; 1991; 60(1):157-65. PubMed ID: 1820705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.
    Bate CA; Taverne J; Román E; Moreno C; Playfair JH
    Immunology; 1992 Jan; 75(1):129-35. PubMed ID: 1537589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of TNF in vitro as a model for the identification of toxic malaria antigens.
    Taverne J; Bate CA; Playfair JH
    Lymphokine Res; 1989; 8(3):317-22. PubMed ID: 2674557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody.
    Taverne J; Bate CA; Playfair JH
    Immunol Lett; 1990 Aug; 25(1-3):207-12. PubMed ID: 2283151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL; Daly TM; Clynes R; Long CA
    J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected problems of malaria blood stage immunity.
    Perlmann P; Perlmann H; Berzins K; Troye-Blomberg M
    Tokai J Exp Clin Med; 1998 Apr; 23(2):55-62. PubMed ID: 10021776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens.
    Bate CA; Taverne J; Bootsma HJ; Mason RC; Skalko N; Gregoriadis G; Playfair JH
    Immunology; 1992 May; 76(1):35-41. PubMed ID: 1628898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for live parasites for long-term immunity in malaria.
    Eling WM; Celluzzi C; Hermsen CC; van de Wiel T; Curfs J; Liem PL
    Acta Leiden; 1991; 60(1):167-75. PubMed ID: 1820706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
    Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
    J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations.
    Kats LM; Wang L; Murhandarwati EE; Mitri K; Black CG; Coppel RL
    Vaccine; 2008 Jun; 26(26):3261-7. PubMed ID: 18468741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.